Item 1. Legal Proceedings
Item 1. Legal Proceedings
For a description of our material legal proceedings, refer to Note 9 of our Notes to Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q, which is incorporated herein by reference.
Item 1A. Ri sk Factors
There have been no material changes to the risk factors described under Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the SEC on February 27, 2024.
Item 2. Unregiste red Sales of Equity Securities and Use of Proceeds
Date Issued
Number of Shares
Grant Date Fair Value
per Share (4)
January 2, 2024
17,500 (1)
$
14.85
January 5, 2024
6,250 (2)
$
13.74
January 15, 2024
123,333 (2)
$
14.94
February 7, 2024
614 (3)
$
16.30
February 9, 2024
4,167 (2)
$
16.78
March 14, 2024
30,180 (3)
$
13.35
(1) Consulting services rendered to the Company.
(2) Pursuant to Development Services Agreements for the development of products and intellectual property.
(3) Independent sales agent services rendered to the Company.
(4) Based on the market price of common stock on the issuance date.
The issuances of the foregoing securities were made in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, as there was no general solicitation and the transactions did not involve a public offering.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.